INTERLEUKIN GENETICS INC (ILI) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 64 transactions totaling $1.1M, demonstrating a bearish sentiment with -$436.2K in net insider flow. The most recent transaction on Mar 31, 2010 involved a transaction of 12,500 shares valued at $9.4K.
No significant insider buying has been recorded for ILI in the recent period.
No significant insider selling has been recorded for ILI in the recent period.
Based on recent SEC filings, insider sentiment for ILI is bearish with an Insider Alignment Score of 29/100 and a net flow of -$436.2K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at INTERLEUKIN GENETICS INC (ILI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading ILI stock, having executed 64 transactions in the past 90 days. The most active insider is Innovations Inc Pyxis (Executive), who has made 2 transactions totaling $2.6M.
Get notified when executives and directors at ILI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 31, 2010 | S. Kornman Kenneth | Executive | Award | 12,500 | $0.75 | $9.4K | |
| Mar 17, 2010 | E. Chowning Mary | Executive | Award | 10,000 | $N/A | $0 | |
| Mar 31, 2009 | S. Kornman Kenneth | Executive | Award | 12,500 | $0.28 | $3.5K | |
| Mar 13, 2009 | H. Bender Lewis | Executive | Award | 110,000 | $0.27 | $29.7K | |
| Mar 13, 2009 | M. Lurier Eliot | Executive | Award | 16,500 | $0.27 | $4.5K | |
| Nov 24, 2008 | H. Bender Lewis | Executive | Purchase | 4,500 | $0.25 | $1.1K | |
| Nov 24, 2008 | H. Bender Lewis | Executive | Purchase | 15,400 | $0.25 | $3.9K | |
| Nov 24, 2008 | H. Bender Lewis | Executive | Purchase | 100 | $0.24 | $24 | |
| Nov 24, 2008 | M. Lurier Eliot | Executive | Purchase | 10,000 | $0.29 | $2.9K | |
| Nov 21, 2008 | E. Chowning Mary | Executive | Purchase | 5,000 | $0.27 | $1.4K | |
| Nov 21, 2008 | E. Chowning Mary | Executive | Purchase | 5,000 | $0.25 | $1.3K | |
| Nov 21, 2008 | H. Bender Lewis | Executive | Purchase | 10,000 | $0.27 | $2.7K | |
| Nov 20, 2008 | H. Bender Lewis | Executive | Purchase | 1,765 | $0.33 | $582 | |
| Nov 20, 2008 | H. Bender Lewis | Executive | Purchase | 8,235 | $0.32 | $2.6K | |
| Nov 20, 2008 | H. Bender Lewis | Executive | Purchase | 1,700 | $0.35 | $595 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 2 | $2.6M | 61.8% |
Sale(S) | 12 | $748.8K | 17.5% |
Purchase(P) | 23 | $312.6K | 7.3% |
Gift(G) | 5 | $248.3K | 5.8% |
Award(A) | 8 | $172.5K | 4.0% |
Exercise(M) | 14 | $152.9K | 3.6% |
Insider selling pressure at INTERLEUKIN GENETICS INC has increased, with 8 insiders executing 64 transactions across all time. Total sales of $748.8K significantly outpace purchases of $312.6K, resulting in a net outflow of $436.2K. This selling activity appears largely discretionary, which may warrant closer attention from investors.